Tokyo, Japan

Emiko Sudo

This inventor holds 1 USPTO granted patent. Top assignee: Freund Industrial Co., Ltd.. Active years: 1988.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Emiko Sudo. Retrieved from https://idiyas.com/inventor/emiko-sudo

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 52(Granted Patents)


Company Filing History:


Years Active: 1988

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Emiko Sudo: Innovator in Pharmaceutical Composition

Introduction

Emiko Sudo is a prominent inventor based in Tokyo, Japan. She has made significant contributions to the field of pharmaceuticals, particularly with her innovative approaches to drug formulation. Her work has the potential to enhance the efficacy of medications that are poorly soluble in water.

Latest Patents

Emiko Sudo holds a patent for a pharmaceutical composition of cyclandelate. This composition features an oral pharmaceutical formulation that includes a polyglycerol ester of an unsaturated fatty acid. The formulation is designed to improve the solubility of drugs that are very slightly soluble in water. She has 1 patent to her name, showcasing her expertise in this specialized area.

Career Highlights

Emiko has been associated with Freund Industrial Co., Ltd., where she has been instrumental in developing innovative pharmaceutical solutions. Her work has garnered attention for its potential to address challenges in drug delivery and formulation.

Collaborations

Emiko has collaborated with notable colleagues, including Shimesu Motoyama and Satoshi Sato. These partnerships have allowed her to expand her research and contribute to advancements in the pharmaceutical industry.

Conclusion

Emiko Sudo is a trailblazer in the field of pharmaceutical innovation. Her contributions, particularly in the development of effective drug formulations, highlight her role as a key inventor in the industry. Her work continues to pave the way for future advancements in pharmaceuticals.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…